A new meta-analysis finds no clear long-term cardiovascular benefit from beta-blockers after myocardial infarction in patients with preserved left ventricular ejection fraction.
This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...
The therapeutic efficacy of the cardiac glycoside digitoxin in patients with heart failure and reduced ejection fraction is not established. In this international, double-blind, placebo-controlled ...
A meta-analysis of recent clinical trials evaluating β-blockers as treatment for patients with acute myocardial infarction ...
Data provide first human validation of cardiac energetics modulation as a therapeutic target in cardiometabolic heart disease, including heart ...
BOSTON -- Early cardiac resynchronization therapy (CRT) benefited patients with moderately reduced ejection fraction (EF) and left bundle branch block (LBBB) but no indication for pacing, according to ...
Ejection fraction (EF) measures how well the heart pumps blood. A normal ejection fraction is between 55% to 70%. A low ejection fraction can be a sign of heart failure. Ejection fraction (EF) ...
"Medical Journeys" is a set of clinical resources reviewed by physicians, meant for the medical team as well as the patients they serve. Each episode of this 12-part journey through a disease state ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback